• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

Integral Technologies, Inc.

  • ID: 620771
  • April 2015
  • 54 Pages
  • Wright Investors Service

A textual analysis of the financial results for Integral Technologies, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description of the company, including contact information, senior officers and Wright Quality Rating analyses is also provided.

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio tables (Accounting, Asset Utilization, Employee Efficiency, Fixed Charges Coverage, Leverage Analysis, Liquidity Analysis, Per-share Data and Profitability Analysis) and proprietary Wright Quality Rating analyses tables. The Wright Quality Rating, a measure of corporate risk, examines the liquidity of the stock, financial strength, profitability and corporate growth characteristics of Integral Technologies, Inc. There is a textual review of the financial results of Integral Technologies, Inc. versus Invisa, Inc., MicroPlanet Technology Corp. and Universal Detection Technology. The comparative analysis of these companies compares Sales READ MORE >

Note: Product cover images may vary from those shown

Company Fundamentals
- Company Profile
- Comparative Business Analysis
- Summary Analysis per Share
- Sales Analysis
- Price Analysis
- Earnings and Dividends Analysis

Financial Statement Analyses
- Balance Sheet - Common Size
- Balance Sheet - Year-Year Percent Change
- Balance Sheet - Five-Year Averages
- Income Statement - Common Size
- Income Statement - Year-Year Percent Change
- Income Statement - Five-Year Averages
- Sources of Capital

Financial Ratio Analyses
- Accounting Ratios
- Asset Utilization
- Employee Efficiency
- Fixed Charges Coverage
- Leverage Analysis
- Liquidity Analysis
- Per-Share Data
- Profitability Analysis

Wright Quality Rating Analyses
- Investment Acceptance
- Financial Strength
- Profitability and Stability
- Corporate Growth

Note: Product cover images may vary from those shown

United States

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

  • Conolog Corporation - Product Thumbnail Image

    Conolog Corporation

    • Language: English
    • 55 Pages
    • Published: December 2014
  • MicroPlanet Technology Corp. (MP) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image
    FROM
  • MicroPlanet Technology Corp. - Product Thumbnail Image

    MicroPlanet Technology Corp.

    • Language: English
    • 55 Pages
    • Published: February 2015
    FROM
  • Nike Inc. - Product Thumbnail Image

    Nike Inc.

    • Language: English
    • 55 Pages
    • Published: April 2015
    FROM
  • Invisa, Inc. - Product Thumbnail Image

    Invisa, Inc.

    • Language: English
    • 56 Pages
    • Published: April 2015
    FROM
  • Samtel India Limited - Product Thumbnail Image

    Samtel India Limited

    • Language: English
    • 54 Pages
    • Published: April 2015
    • Region: India
    FROM
  • Ross Group PLC - Product Thumbnail Image

    Ross Group PLC

    • Language: English
    • 54 Pages
    • Published: May 2015
    FROM
  • Simon Property Group, Inc. - Product Thumbnail Image

    Simon Property Group, Inc.

    • Language: English
    • 39 Pages
    • Published: April 2015
    FROM
  • Cia de Distribucion Integral Logista Hldg SA - Product Thumbnail Image Cia de Distribucion Integral Logista Hldg SA

    Cia de Distribucion Integral Logista Hldg SA

    • Language: English
    • 51 Pages
    • Published: April 2015
    FROM
  • Telefonica SA - Product Thumbnail Image

    Telefonica SA

    • Language: English
    • 57 Pages
    • Published: April 2015
    FROM

Our Clients

Fluidigm Corporation Apple, Inc. CEVA Santé Animale Abbott Laboratories Ltd. Merck Group Allergan Inc. Pfizer, Inc.